b.
Psychosocial evaluations should determine if further psychosocial or behavioral
interventions are indicated for patients diagnosed with chronic pain. The
interpretations of the evaluation should provide clinicians with a better
understanding of the patient in his or her social environment, thus allowing
for more effective rehabilitation. Psychosocial assessment requires
consideration of variations in pain experience and expression resulting from
affective, cognitive, motivational and coping processes, and other influences
such as gender, age, race, ethnicity, national origin, religion, sexual
orientation, disability, language, or socioeconomic status.
i. Frequency: one-time visit for the clinical
interview. If psychometric testing is indicated as a part of the initial
evaluation, time for such testing should not exceed an additional two hours of
professional time.
(a). Clinical Evaluation:
All chronic pain patients should have a clinical evaluation that addresses the
following areas:
(i). History of Injury - The
history of the injury should be reported in the patient's words or using
similar terminology. Caution must be exercised when using translators.
[b]. psychosocial circumstances of the
injury;
[c]. current symptomatic
complaints;
[d]. extent of medical
corroboration;
[e]. treatment
received and results;
[f].
compliance with treatment;
[g].
coping strategies used, including perceived locus of control;
[h]. perception of medical system and
employer;
[i]. history of response
to prescription medications.
(ii). Health History
[c]. psychiatric history;
[d]. history of alcohol or substance
abuse;
[e]. activities of daily
living;
[g]. previous injuries,
including disability, impairment, and compensation
(iii). Psychosocial History
[a]. childhood history, including
abuse;
[b]. educational
history;
[c]. family history,
including disability;
[d]. marital
history and other significant adulthood activities and events;
[e]. legal history, including criminal and
civil litigation;
[f]. employment
and military history;
[g]. signs of
pre-injury psychological dysfunction;
[h]. current interpersonal relations,
support, living situation;
(iv).
Psychological test results, if performed
(v). Danger to self or others.
(vi). Current psychiatric diagnosis
consistent with the standards of the American Psychiatric Association's
Diagnostic and Statistical Manual of Mental Disorders.
(vii). Pre-existing psychiatric conditions.
Treatment of these conditions is appropriate when the pre-existing condition
affects recovery from chronic pain.
(viii). Causality (to address medically
probable cause and effect, distinguishing pre-existing psychological symptoms,
traits and vulnerabilities from current symptoms).
(ix). Treatment recommendations with respect
to specific goals, frequency, timeframes, and expected
outcomes.
(b). Tests of
Psychological Functioning: Psychometric Testing is a valuable component of a
consultation to assist the physician in making a more effective treatment plan.
Psychometric testing is useful in the assessment of mental conditions, pain
conditions, cognitive functioning, treatment planning, vocational planning, and
evaluation of treatment effectiveness. There is no general agreement as to
which standardized psychometric tests should be specifically recommended for
psychological evaluations of chronic pain conditions. It is appropriate for the
mental health provider to use their discretion and administer selective
psychometric tests within their expertise and within standards of care in the
community. Some of these tests are available in Spanish and other languages,
and many are written at a sixth grade reading level. Examples of frequently
used psychometric tests performed include, but not limited to, the following.
(i). Comprehensive Inventories for Medical
Patients
[a]. Battery for Health Improvement,
2nd Edition (BHI-2). What it measures Depression, anxiety and hostility;
violent and suicidal ideation; borderline, dependency, chronic maladjustment,
substance abuse, conflicts with work, family and physician, pain preoccupation,
somatization, perception of functioning and others. Benefits When used as a
part of a comprehensive evaluation, can contribute substantially to the
understanding of psychosocial factors underlying pain reports, perceived
disability, somatic preoccupation, and help to design interventions. Serial
administrations can track changes in a broad range of variables during the
course of treatment, and assess outcome.
[b]. Millon Behavioral Medical Diagnostic
(MBMD). What it Measures Updated version of the Millon Behavioral Health
Inventory (MBHI). Provides information on Coping Styles (introversive,
inhibited, dejected, cooperative, sociable, etc), Health Habits (smoking,
drinking, eating, etc.), Psychiatric Indications (anxiety, depression, etc),
stress moderators (Illness Apprehension vs. Illness Tolerance, etc), treatment
prognostics (Interventional Fragility vs. Interventional Resilience, Medication
Abuse vs. Medication Competence, etc) and other factors. Benefits When used as
a part of a comprehensive evaluation, can contribute substantially to the
understanding of psychosocial factors affecting medical patients. Understanding
risk factors and patient personality type can help to optimize treatment
protocols for a particular patient.
[c]. Pain Assessment Battery (PAB). What it
measures - collection of four separate measures that are administered together.
Emphasis on the assessment of pain, coping strategies, degree and frequency of
distress, health-related behaviors, coping success, beliefs about pain, quality
of pain experience, stress symptoms analysis, and others. Benefits-When used as
a part of a comprehensive evaluation, can contribute substantially to the
understanding of patient stress, pain reports and pain coping strategies, and
help to design interventions. Serial administrations can track changes in
measured variables during the course of treatment, and assess
outcome.
ii. Comprehensive Psychological Inventories.
These tests are designed for detecting various psychiatric syndromes, but in
general are more prone to false positive findings when administered to medical
patients.
(a). Millon Clinical Multiaxial
Inventory, 3rd Edition (MCMI-III). What it measures - has scales based on DSM
diagnostic criteria for affective, personality, and psychotic disorders and
somatization. Benefits - when used as a part of a part of a comprehensive
evaluation, can screen for a broad range of DSM diagnoses.
(b). Minnesota Multiphasic Personality
Inventory, 2nd Edition (MMPI-2). What it measures - original scale constructs,
such as hysteria and psychesthenia are archaic but continue to be useful. Newer
content scales include depression, anxiety, health concerns, bizarre mentation,
social discomfort, low self-esteem, and almost 100 others. Benefits When used
as a part of a comprehensive evaluation, measure a number of factors that have
been associated with poor treatment outcome.
(c). Personality Assessment Inventory (PAI).
What it measures - a good measure of general psychopathology. Measures
depression, anxiety, somatic complaints, stress, alcohol and drug use reports,
mania, paranoia, schizophrenia, borderline, antisocial, and suicidal ideation
and more than 30 others. Benefits When used as a part of a comprehensive
evaluation, can contribute substantially to the identification of a wide
variety of risk factors that could potentially affect the medical
patient.
iii. Brief
Multidimensional Screens for Medical Patients. Treating providers, to assess a
variety of psychological and medical conditions, including depression, pain,
disability and others, may use brief instruments. These instruments may also be
employed as repeated measures to track progress in treatment, or as one test in
a more comprehensive evaluation. Brief instruments are valuable in that the
test may be administered in the office setting and hand scored by the
physician. Results of these tests should help providers distinguish which
patients should be referred for a specific type of comprehensive evaluation.
(a). Brief Battery for Health Improvement,
2nd Edition (BBHI-2). What it measures Depression, anxiety, somatization, pain,
function, and defensiveness. Benefits Can identify patients needing treatment
for depression and anxiety, and identify patients prone to somatization, pain
magnification and self-perception of disability. Can compare the level of
factors above to other pain patients and community members. Serial
administrations can track changes in measured variables during the course of
treatment, and assess outcome.
(b).
Multidimensional Pain Inventory (MPI). What it measures - interference,
support, pain severity, life-control, affective distress, response of
significant other to pain, and self-perception of disability at home and work,
and in social and other activities of daily living. Benefits Can identify
patients with high levels of disability perceptions, affective distress, or
those prone to pain magnification. Serial administrations can track changes in
measured variables during the course of treatment, and assess
outcome.
(c). Pain Patient Profile
(P3). What it measures Assesses depression, anxiety, and somatization. Benefits
Can identify patients needing treatment for depression and anxiety, as well as
identify patients prone to somatization. Can compare the level of depression,
anxiety and somatization to other pain patients and community members. Serial
administrations can track changes in measured variables during the course of
treatment, and assess outcome.
(d).
SF-36 a. What it measures - a survey of general health well-being and
functional states. Benefits - assesses a broad spectrum of patient disability
reports. Serial administrations could be used to track patient perceived
functional changes during the course of treatment, and assess
outcome.
(e). Sickness Impact
Profile (SIP). What it measures - perceived disability in the areas of sleep,
eating, home management, recreation, mobility, body care, social interaction,
emotional behavior, and communication. Benefits - assesses a broad spectrum of
patient disability reports. Serial administrations could be used to track
patient perceived functional changes during the course of treatment, and assess
outcome.
(f). McGill Pain
Questionnaire (MPQ). What it measures - cognitive, emotional and sensory
aspects of pain. Benefits - can identify patients prone to pain magnification.
Repeated administrations can track progress in treatment for pain.
(g). McGill Pain Questionnaire - Short Form
(MPQ-SF). What it measures - emotional and sensory aspects of pain. Benefits -
can identify patients prone to pain magnification. Repeated administrations can
track progress in treatment for pain.
(h). Oswestry Disability Questionnaire. What
it measures - disability secondary to low back pain. Benefits - can measure
patients' self-perceptions of disability. Serial administrations could be used
to track changes in self-perceptions of functional ability during the course of
treatment, and assess outcome.
(i).
Visual Analog Scales (VAS). What it measures - graphical measure of patient's
pain report. Benefits - quantifies the patients' pain report. Serial
administrations could be used to track changes in pain reports during the
course of treatment and assess outcome.
iv. Brief Multidimensional Screens for
Psychiatric Patients. These tests are designed for detecting various
psychiatric syndromes, but in general are more prone to false positive findings
when administered to medical patients.
(a).
Brief Symptom Inventory. What it measures: Somatization, obsessive-compulsive,
depression, anxiety, phobic anxiety, hostility, paranoia, psychoticism, and
interpersonal sensitivity. Benefits: Can identify patients needing treatment
for depression and anxiety, as well as identify patients prone to somatization.
Can compare the level of depression, anxiety, and somatization to community
members. Serial administrations could be used to track changes in measured
variables during the course of treatment, and assess outcome.
(b). Brief Symptom Inventory - 18 (BSI-18).
What it Measures: Depression, anxiety, somatization. Benefits: Can identify
patients needing treatment for depression and anxiety, as well as identify
patients prone to somatization. Can compare the level of depression, anxiety,
and somatization to community members. Serial administrations could be used to
track patient perceived functional changes during the course of treatment, and
assess outcome.
(c). Symptom Check
List 90 (SCL 90). What it measures: Somatization, obsessive-compulsive,
depression, anxiety, phobic anxiety, hostility, paranoia, psychoticism, and
interpersonal sensitivity. Benefits: Can identify patients needing treatment
for depression and anxiety, as well as identify patients prone to somatization.
Can compare the level of depression, anxiety and somatization to community
members. Serial administrations could be used to track changes in measured
variables during the course of treatment, and assess outcome.
v. Brief Specialized Psychiatric
Screening Measures
(a). Beck Depression
Inventory (BDI). What it measures: Depression. Benefits: Can identify patients
needing referral for further assessment and treatment for depression and
anxiety, as well as identify patients prone to somatization. Repeated
administrations can track progress in treatment for depression, anxiety, and
somatic preoccupation.
(b). Post
Traumatic Stress Diagnostic Scale (PDS). What it Measures: Post Traumatic
Stress Disorder (PTSD). Benefits: Helps confirm suspected PTSD diagnosis.
Repeated administrations can track treatment progress of PTSD
patients.
(c). Center of
Epidemiologic Studies - Depression Questionnaire. What it measures: Depression.
Benefits: Brief self-administered screening test. Requires professional
evaluation to verify diagnosis.
(d). Brief Patient Health Questionnaire from
PRIME - MD. What it measures: Depression, panic disorder. Benefits: Brief
self-administered screening test. Requires professional evaluation to verify
diagnosis.
(e). Zung Questionnaire.
What it measures: Depression. Benefits: Brief self-administered screening test.
Requires professional evaluation to verify diagnosis.
(f). Diagnostic Studies. Imaging of the spine
and/or extremities is a generally accepted, well-established, and widely used
diagnostic procedure when specific indications, based on history and physical
examination, are present. Physicians should refer to individual OWCA guidelines
for specific information about specific testing procedures.
(g). Radiographic Imaging, MRI, CT, bone
scan, radiography, SPECT and other special imaging studies may provide useful
information for many musculoskeletal disorders causing chronic pain. Single
Photon Emission Computerized Tomography (SPECT): A scanning technique which may
be helpful to localize facet joint pathology and is useful in determining which
patients are likely to have a response to facet injection. SPECT combines bone
scans & CT Scans in looking for facet joint pathology.
(h). Electrodiagnostic studies may be useful
in the evaluation of patients with suspected myopathic or neuropathic disease
and may include Nerve Conduction Studies (NCS), Standard Needle
Electromyography, or Somatosensory Evoked Potential (SSEP). The evaluation of
electrical studies is difficult and should be relegated to specialists who are
well trained in the use of this diagnostic procedure.
(i). Special Testing Procedures may be
considered when attempting to confirm the current diagnosis or reveal
alternative diagnosis. In doing so, other special tests may be performed at the
discretion of the physician.
(j).
Testing for complex regional pain syndrome (CRPS-I) or sympathetically
maintained pain (SMP) is described in the Complex Regional Pain Syndrome/Reflex
Sympathetic Dystrophy Medical Treatment Guidelines.